Chphilia focused on the bio-technique achievements in aesthetic medicine development through combining clinical use performed by the FDA of the U.S., stem cell regeneration techniques developed in Japan, and immunotherapy treatments established in Germany. Chphilia specializes in four major enterprises - Cell Regeneration, Anti-aging, Disease Prevention, and Disease Therapeutics. Through a group of international professional Scientific Advisory Boards, we engaged in the development and technology transfer of effective medical products and drugs. Under the rigorous attitude of science and medicine background, Chphilia providing an effective and safe medical latest technology to achieve the optimal treatment benefits for our doctor.